After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .
Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
PURPOSE The purpose of this study was to evaluate the total success rates of mineral trioxide aggregate ( MTA ) , ferric sulfate ( FS ) , and formocresol ( FC ) as pulpotomy agents in primary molars . METHODS A r and omized , split-mouth study design was used in 32 healthy 5- to 7-year-old children with 128 carious primary molars without clinical or radiographic evidence of pulp degeneration . The pulpotomy agents were assigned as follows : Group 1=MTA ; Group 2=FS ; Group 3=1:5 diluted Buckley 's FC ; and Group 4=zinc oxide eugenol ( ZOE ) base . Clinical and radiographic follow-up at 6 , 12 , and 24 months used the following criteria : pain ; swelling ; sinus tract ; mobility ; internal root resorption ; and furcation and /or periapical bone destruction . The data were analyzed using chi-square . RESULTS No significant differences in success rates were found among the groups at 6 and 12 months . Success rates in groups 1 to 4 at 24 months were 96 % , 88 % , 88 % , and 68 % respectively . There was a significant difference ( P<.001 ) between the MTA and ZOE groups at 24 months . CONCLUSIONS ZOE , as the only pulpotomy medicament , had a significantly lower success rate than MTA . No significant differences were observed , among the 3 experimental material s ( MTA , FC , and FS ) at 2 years follow-up
After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .